Status:
COMPLETED
Long Term Follow Up Study to COMP 001 And COMP 003 Trials (P-TRD LTFU)
Lead Sponsor:
COMPASS Pathways
Conditions:
Treatment Resistant Depression
Eligibility:
All Genders
18-55 years
Brief Summary
The primary objective of this study is to assess the long-term efficacy of psilocybin with respect to use of new antidepressant treatment, hospitalisations for depression, suicidality, and depressive ...
Detailed Description
In this present study (COMP 004), the aim is to follow up participants from COMP 001 and COMP 003 in a long-term follow up study, with both remote and digital assessments, to explore the long term eff...
Eligibility Criteria
Inclusion
- Signed ICF Each participant having completed the final study visit of either COMP 001 or COMP 003 Ability to complete all protocol required assessment tools (including having access to the internet in order to complete the digital assessments) without any assistance or alteration to the copyrighted assessments, and to comply with all study visits
Exclusion
- Subject has any condition, for which in the opinion of the investigator, participation would not be in the interest of the subject eg participation could compromise the wellbeing of the participant or prevent, limit, or confound the protocol-specified assessments
Key Trial Info
Start Date :
July 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 11 2022
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT04519957
Start Date
July 20 2020
End Date
August 11 2022
Last Update
September 22 2022
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Kadima Neuropsychiatry Institute
La Jolla, California, United States, 92037
2
Altman Clinical and Translational Research Institute, University of California
San Diego, California, United States, 92093
3
Mood and Anxiety Disorders Program Emory University School of Medicine
Atlanta, Georgia, United States, 30329
4
UT Center of Excellence on Mood Disorders, University of Texas Health Science Center
Houston, Texas, United States, 77054